IMMUNESENSOR THERAPEUTICS, INC.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.immunesensor.com
A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial
- Conditions
- Solid Tumor, Adult
- Interventions
- Drug: Immune Checkpoint Inhibitor
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- ImmuneSensor Therapeutics Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT06026254
- Locations
- 🇺🇸
Honor Health, Scottsdale, Arizona, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States
Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies
- Conditions
- Oligoprogressive
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- ImmuneSensor Therapeutics Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT05846659
- Locations
- 🇺🇸
City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸UCLA, Los Angeles, California, United States
Study of PULSAR-ICI +/- IMSA101 in Patients with Oligometastatic NSCLC and RCC
- Conditions
- Oligometastatic Disease
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- ImmuneSensor Therapeutics Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05846646
- Locations
- 🇺🇸
City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States
🇺🇸The University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Safety and Efficacy Study of IMSA101 in Refractory Malignancies
- Conditions
- Solid Tumor, Adult
- Interventions
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- ImmuneSensor Therapeutics Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04020185
- Locations
- 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸UT Southwestern, Dallas, Texas, United States